{"filings":[{"id":1113757,"accession_number":"0001079973-26-000855","cik":1128189,"company_name":"ProtoKinetix, Inc.","ticker":"PKTX","form_type":"8-K","filed_at":"2026-06-17T21:28:41+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"ProtoKinetix appoints new President, forms SightPath Biotech, patents valued at $253M","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Director McDonough resigned March 31; June 17: Jones, Lamp, Brunt appointed directors, Brunt as President.","Formed SightPath Biotech LLC for dry-eye drug PKX-001; patent valuation ~$253M per IQVIA & Benoit & Cote studies.","Late filings: 2025 10-K (Mar 31) and Q1 2026 10-Q (May 15); company still working to complete.","Repriced 61.19M options and 6M warrants from $0.028 to $0.01, extended expiry to Dec 2030."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2252369.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117884,"accession_number":"0001553350-25-000111","cik":1128189,"company_name":"ProtoKinetix, Inc.","ticker":"PKTX","form_type":"8-K","filed_at":"2025-11-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ProtoKinetix CEO updates on founder Clarence Smith's passing and AAGP molecule strategy","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["CEO Guzzetta acknowledges sudden passing of longtime leader Clarence Smith and commitment to his vision.","Company continues development of first-in-class synthetic glycopeptide AAGP (PKX-001) for cell protection and inflammation control.","Global patent portfolio covers US, Europe, UK, Asia; outreach to pharma firms for Type 1 Diabetes, cell therapy, dry-eye, and topical applications.","No financial or operational metrics provided; update is a stockholder letter with no specific milestones."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":2252369.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117881,"accession_number":"0001079973-25-001802","cik":1128189,"company_name":"ProtoKinetix, Inc.","ticker":"PKTX","form_type":"8-K/A","filed_at":"2025-11-19T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"ProtoKinetix CEO Clarence Smith dies in accident; CFO Guzzetta named successor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["President & CEO Clarence E. Smith died in a tragic accident on November 13, 2025.","Michael Guzzetta appointed Chairman, President, and CEO on November 16, 2025.","Guzzetta will also continue as CFO, Secretary, and Treasurer of the clinical-stage biotech.","This 8-K/A corrects the contact number in the prior filing and adds the press release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2252369.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117883,"accession_number":"0001079973-25-001778","cik":1128189,"company_name":"ProtoKinetix, Inc.","ticker":"PKTX","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"ProtoKinetix CEO Clarence Smith dies in accident; CFO Guzzetta assumes all top roles","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Clarence E. Smith died Nov 13, 2025 in a tragic accident; served as CEO since 2015.","Sole remaining director Ed McDonough appointed Michael Guzzetta as Chairman, CEO, President on Nov 16.","Guzzetta continues as CFO, Secretary, Treasurer; his 2017 employment agreement unchanged.","ProtoKinetix is a clinical-stage biomedical company (OTC: PKTX) with no disclosed financial impact."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":2252369.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117882,"accession_number":"0001079973-25-001594","cik":1128189,"company_name":"ProtoKinetix, Inc.","ticker":"PKTX","form_type":"8-K","filed_at":"2025-10-10T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"ProtoKinetix shareholders approve 20% increase in authorized common shares to 600M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved amendment raising authorized shares from 500M to 600M; 222,125,724 votes in favor.","Consent solicitation closed October 6, 2025; holders of 57.1% of outstanding shares consented.","Record date was September 5, 2025, with 389,080,152 shares outstanding and entitled to vote.","Certificate of Amendment filed October 9, 2025, effective as of that date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2252369.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}